Antares Pharma
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Antares Pharma sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Antares Pharma: 9 sponsored US clinical trials, none currently recruiting.
Antares Pharma sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 3 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rheumatoid Arthritis (RA), with 1 trials.
Top-decile sponsor footprint
Antares Pharma ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NCT02777242
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
NCT02504541
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
NCT02233751
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
NCT02159469
Pharmacokinetic Study of Testosterone Enanthate
NCT01887418
Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device
NCT01618968
Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device
NCT01618955
Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
NCT01737944
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
NCT00909181
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 3 |
Therapeutic Areas
How the Antares Pharma early-phase archive is shaped
9 indexed studies, none listed as recruiting (0% open); 9 completed (100%).
Phase mix: 3 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Rheumatoid Arthritis (RA) (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Antares Pharma: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Antares Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Antares Pharma page
9 registered trials is a research-attention snapshot, not an endorsement of Antares Pharma or any single study.
- None of Antares Pharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Rheumatoid Arthritis (RA) is the condition Antares Pharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rheumatoid Arthritis (RA) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Antares Pharma pipeline card: 9 registered trials from official public datasets.Report a data error.